论文部分内容阅读
慢性肺源性心脏病 (肺心病 )患者血液粘滞性明显增高 ,并有多发性原位小血栓形成[1] 。我们自1999年 5月以来 ,采用低分子肝素辅助治疗慢性肺心病 ,取得了良好效果。1 对象和方法1 1 对象 15 6例均符合 1980年全国肺心病专业会议制定的慢性肺心病急性加重期标准 ,其中男 85
Patients with chronic cor pulmonale (pulmonary heart disease) patients with significantly increased blood viscosity, and multiple in situ small thrombosis [1]. We have been using low molecular weight heparin to treat chronic pulmonary heart disease since May 1999 and have achieved good results. 1 Subjects and methods 1 1 object 15 6 cases are in line with the National Conference of Cor Pulmonary in 1980 developed acute exacerbation of chronic pulmonary heart disease criteria, of which 85